FDA-ClearedStrong EvidenceMusculoskeletal
Refractory Osteomyelitis
HBOT enhances white blood cell killing ability in hypoxic bone, improves antibiotic delivery, stimulates bone remodeling, and promotes angiogenesis in devascularized bone.
Typical Protocol at a Glance
Pressure
2.4 ATA
Duration
90 min
Sessions
40
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.